Regenerx Biopharm In Stock Market Value
| RGRX Stock | USD 0.0003 0.00 0.00% |
| Symbol | Regenerx |
Regenerx Biopharm 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Regenerx Biopharm's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Regenerx Biopharm.
| 12/12/2025 |
| 01/11/2026 |
If you would invest 0.00 in Regenerx Biopharm on December 12, 2025 and sell it all today you would earn a total of 0.00 from holding Regenerx Biopharm In or generate 0.0% return on investment in Regenerx Biopharm over 30 days. RegeneRx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapeutic peptide, thymo... More
Regenerx Biopharm Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Regenerx Biopharm's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Regenerx Biopharm In upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.1228 | |||
| Maximum Drawdown | 79999.88 |
Regenerx Biopharm Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Regenerx Biopharm's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Regenerx Biopharm's standard deviation. In reality, there are many statistical measures that can use Regenerx Biopharm historical prices to predict the future Regenerx Biopharm's volatility.| Risk Adjusted Performance | 0.1014 | |||
| Jensen Alpha | 1315.12 | |||
| Total Risk Alpha | 93.99 | |||
| Treynor Ratio | (0.95) |
Regenerx Biopharm Backtested Returns
Regenerx Biopharm is out of control given 3 months investment horizon. Regenerx Biopharm maintains Sharpe Ratio (i.e., Efficiency) of 0.11, which implies the firm had a 0.11 % return per unit of risk over the last 3 months. We were able to interpolate data for sixteen different technical indicators, which can help you to evaluate if expected returns of 13.5% are justified by taking the suggested risk. Use Regenerx Biopharm Variance of 9.67333425E7, risk adjusted performance of 0.1014, and Coefficient Of Variation of 813.95 to evaluate company specific risk that cannot be diversified away. Regenerx Biopharm holds a performance score of 8 on a scale of zero to a hundred. The company holds a Beta of -1267.25, which implies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Regenerx Biopharm are expected to decrease by larger amounts. On the other hand, during market turmoil, Regenerx Biopharm is expected to outperform it. Use Regenerx Biopharm standard deviation and kurtosis , to analyze future returns on Regenerx Biopharm.
Auto-correlation | 0.00 |
No correlation between past and present
Regenerx Biopharm In has no correlation between past and present. Overlapping area represents the amount of predictability between Regenerx Biopharm time series from 12th of December 2025 to 27th of December 2025 and 27th of December 2025 to 11th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Regenerx Biopharm price movement. The serial correlation of 0.0 indicates that just 0.0% of current Regenerx Biopharm price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Regenerx Biopharm lagged returns against current returns
Autocorrelation, which is Regenerx Biopharm otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Regenerx Biopharm's otc stock expected returns. We can calculate the autocorrelation of Regenerx Biopharm returns to help us make a trade decision. For example, suppose you find that Regenerx Biopharm has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Regenerx Biopharm regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Regenerx Biopharm otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Regenerx Biopharm otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Regenerx Biopharm otc stock over time.
Current vs Lagged Prices |
| Timeline |
Regenerx Biopharm Lagged Returns
When evaluating Regenerx Biopharm's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Regenerx Biopharm otc stock have on its future price. Regenerx Biopharm autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Regenerx Biopharm autocorrelation shows the relationship between Regenerx Biopharm otc stock current value and its past values and can show if there is a momentum factor associated with investing in Regenerx Biopharm In.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Regenerx OTC Stock Analysis
When running Regenerx Biopharm's price analysis, check to measure Regenerx Biopharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regenerx Biopharm is operating at the current time. Most of Regenerx Biopharm's value examination focuses on studying past and present price action to predict the probability of Regenerx Biopharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regenerx Biopharm's price. Additionally, you may evaluate how the addition of Regenerx Biopharm to your portfolios can decrease your overall portfolio volatility.